Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OFATUMUMAB vs OLMESARTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OFATUMUMAB vs OLMESARTAN: Safety Overview

Metric OFATUMUMAB OLMESARTAN
Total FAERS Reports 29,913 2,228
Deaths Reported 695 77
Death Rate 2.3% 3.5%
Hospitalizations 3,616 1,096
Average Patient Age 47.5 yrs 68.9 yrs
% Female Patients 74.9% 52.8%
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A